ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
China NMPA Approves MicuRx's Contezolid for Treatment of Drug-Resistant Bacterial Infection
June 04, 2021MicuRx Pharmaceutical Co., Ltd. announced that China National Medical Products Administration (NMPA) has approved its new drug application for contezolid as the treatment of complicated skin and soft tissue infection. -
MicuRx Commits Funding for Development of MRX-8
August 18, 2020MicuRx Pharmaceuticals announced the global partnership Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) has committed up to US$7.78 million of nondilutive financing for a Phase 1 clinical trial and related R&D activities ... -
MicuRx Announces Closing of ¥100 Million Funding
December 08, 2017MicuRx Pharmaceuticals, Inc. today announced closing of ¥100 million private financing led by Chinese affiliates of the existing MicuRx investors Delian Capital and BVCF
Pharma Sources Insight January 2025
